Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
Stem cell technology
CeMM and Haplogen reveal the world's largest collection of engineered human cell lines for biomedical discovery
Stem cell technology : 27 August, 2013
Haplogen, a biotechnology company developing antiviral therapies, and CeMM, the Center for Molecular Medicine of the Austrian Academy of Sciences, are making available their large collection of human cell lines that are deficient for single genes, which they have been building over the past three years as part of a public-private partnership.
 
Neuralstem cells are shown to reverse cognitive defect in brain-irradiated rats
Stem cell technology : 02 August, 2013
A paper published in the journal 'Cell Transplantation - The Regenerative Medicine Journal', reports that Neuralstem's spinal cord-derived human neural stem cells, NSI-566, improved cognitive function in rats who'd received radiation to the brain, as assessed by two separate cognitive tasks.
 
LifeMap Sciences releases LifeMap Discovery Version 1.2 with extensive stem cell therapy data
Stem cell technology : 29 July, 2013
LifeMap Sciences is releasing LifeMap Discovery version 1.2 which is a state-of-the-art roadmap of embryonic development and stem cell biology.
 
Study shows Neuralstem stem cells induce improvement in acute spinal cord injury rats
Stem cell technology : 30 May, 2013
Neuralstem is reporting that a paper published in the journal, Stem Cell Research and Therapy showed that rats transplanted with its spinal cord-derived human neural stem cells, NSI-566, three days after a spinal cord injury at L3 (lumbar 3), showed improvement along several measures of motor function and a reduction of spasticity.
 
Sinagapore single-cell research centre opens to support single-cell genomic applications
Stem cell technology : 29 April, 2013
The Single-Cell Omics Centre (SCOC) in Singapore is now offically open making the research centre the first in Asia exclusively dedicated to accelerating the understanding of how individual cells work, and how diagnosis and treatment might be enhanced through insight derived from single cells.
 
Neuralstem receives FDA approval to start Phase II stem cell trial in ALS trial
Stem cell technology : 19 April, 2013
Neuralstem receives approval from the Food and Drug Administration to commence a Phase II trial using NSI-566 spinal cord-derived human neural stem cells in the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).
 
Roche partners BioLamina to develop novel cell culture systems
Stem cell technology : 08 March, 2013
Roche signs a research and development agreement with BioLamina to jointly develop new cell culture systems for various applications, including stem cell research.
 
Cytori receives CE Mark for specialised cell therapy reagent for intravascular delivery
Stem cell technology : 26 February, 2013
Cytori Therapeutics receives a CE Mark in Europe for Intravase, a reagent intended to be used with Cytori's Celution System for preparing safe and optimised adipose-derived stem and regenerative cells (ADRCs) for intravascular delivery into the same patient.
 
New freezing procedure increases availability of cord blood stem cell transplants
Stem cell technology : 12 February, 2013
Researchers from the Etablissement Francais du Sang, Aquitaine-Limousin (France) establish a method to multiply cord blood stem cells to required quantity levels to ensure the success of a cord blood transplant.
 
Neuralstem approved to begin ischemic stroke trial In China
Stem cell technology : 01 October, 2012
Neuralstem is approved to commence a clinical trial to treat motor deficits due to ischemic stroke with its spinal cord stem cells (NSI-566) at BaYi Brain Hospital, in Beijing, China, through its subsidiary, Neuralstem China (Suzhou Neuralstem Biopharmaceutical).
 
Life Technologies agrees stem partnership with Cellular Dynamics International
Stem cell technology : 14 June, 2012
Life Technologies is forming a partnership with Cellular Dynamics International (CDI), the world's largest producer of human cells derived from induced pluripotent stem (iPS) cells, to commercialise a set of three new products optimised to consistently develop and grow human iPS cells for both research and bioproduction.
 
PerkinElmer improves stem cell collection premature births
Stem cell technology : 21 December, 2011
PerkinElmer's family cord blood banking business, ViaCord, is entering into a collaborative study with Miracle Babies, a non-profit organization supporting families with newborns in Neonatal Intensive Care Units (NICU).
 
Fluid concentrator device aims to advance regenerative medicine
Stem cell technology : 28 July, 2010
Circle Biologics is claiming a break-through in regenerative medicine with its Autologous Platelet Concentrator Platform (APC) which is an innovative single device platform that is the first of its kind to incorporate both autologous (patient derived) cell concentration and protein concentration in one point-of-care device.
 
NeoStem partners IR BioSciences to develop stem cell products
Stem cell technology : 28 April, 2010
NeoStem, an international biopharmaceutical company with operations in the USA and China and ImmuneRegen BioSciences, a wholly owned subsidiary of IR BioSciences, are entering into a Collaborative Research Agreement, focused on the development of an advanced, adult human stem cell product.
 
SRU Biosystems extends label-free instrumentation offering
Stem cell technology : 08 April, 2010
SRU Biosystems is extending its product line of label-free instrumentation and biosensors with the introduction of its BIND SCANNER for primary and stem cell applications.
 
Ambry Genetics offers higher resolution stem cell analysis tool
Stem cell technology : 22 January, 2010
Ambry Genetics introduces the company’s new StemArray product and services utilising aCGH technology to cover the entire genome.
 
Neuralstem to begin Phase I trial stem cell treatment for ALS
Stem cell technology : 21 December, 2009
Neuralstem announces the company’s Phase I trial to treat Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease) with its spinal cord stem cells has been approved by the Institutional Review Board (IRB) at Emory University in Atlanta, Georgia.
 
FDA meeting held on stem cell treatment related IND
Stem cell technology : 19 October, 2009
First stage completed by Stemedica in gaining approvals for investigative drug analysis relating to the company’s use of bone marrow derived stem cell treatment for stroke victims
 
Animal-Protein Free maintenance medium for HESC and HIPSC
Stem cell technology : 15 October, 2009
TeSR2 from Stemcell Technologies provides researches with a defined animal-protein free medium for human embryonic and induced pluripotent stem cells
 
Russian and Swiss stem cell technology scientists meet at Crossing Visions summit
Stem cell technology : 21 September, 2009
Stemedica’s president has delivered a presentation on advances in stem cell technology at a forum bringing together Swiss and Russian experts in collaborative gathering
 
Medical technology company hosts member of the Russian State Duma
Stem cell technology : 14 September, 2009
Russia’s Hi-Tech Development Subcommittee Chairman visits headquarters of InVivo Technology as part of emerging technology tour
 
Tissue derived stem cell conference schedule
Stem cell technology : 11 September, 2009
Cytori Therapeutics provides its schedule of demonstration of stem and regenerative cells in the US through until December
 
Technology from Stemedica to be used by Jordanian Stem Cell Company
Stem cell technology : 08 September, 2009
Advances in treatments for Jordanian citizens envisaged in deal for stem cell technology between the Jordanian Stem Cell Company and Stemedica
 
Advances in cell-based cancer therapy
Stem cell technology : 07 September, 2009
Stem cell technology from Vitro Diagnostics may provide an alternative cell-based treatment for brain cancer
 
Stem Cell Training Courses in Vancouver
Stem cell technology : 04 September, 2009
Stemcell Technologies is hosting a series of training courses in different aspects of stem cell biology throughout October and November at its Vancouver location
 
License won for human stem cell trials
Stem cell technology : 02 September, 2009
California has awarded a license to Stemedica to manufacture stem cells for human clinical trials
 
Sigma-Aldrich adds HyStem ECM products to its stem cell research portfolio
Stem cell technology : 17 August, 2009
Sigma-Aldrich signs an agreement with Glycosan BioSystems for the sale of HyStem, a fully customizable synthetic extracellular matrix (ECM) for stem cell research.
 
NeoStem agrees deal with Enhance BioMedical to develop adult stem cell collection network in Asia
Stem cell technology : 16 June, 2009
NeoStem signs an exclusive 10-year agreement with Enhance BioMedical, a Shanghai corporation, to develop a Stem Cell Collection and Treatment Network using NeoStem's proprietary adult stem cell technologies in Shanghai, Taiwan as well as the Chinese provinces of Jiangsu, Zhejiang, Fujian, Anhui and Jiangxi.
 
UPCI joins group of cancer centres to take part in the ExCell research study of StemEx
Stem cell technology : 16 June, 2009
The University of Pittsburgh Cancer Institute (UPCI) and the Gamida Cell - Teva Joint Venture announces that the Institute has joined an elite group of cancer centres in Europe, the USA and Israel that are now enrolling patients to participate in the ExCell research study.
 
Harvest Technologies partners LifeCell International to target Indian stem cell research sector
Stem cell technology : 04 June, 2009
Harvest Technologies, a world leader in point of care autologous stem cells, agrees a sale and marketing relationship with LifeCell International, India's first and the largest stem cell banking service provider, and a pioneer in stem cell research and technology in India.
 
StemCyte passes 1,000th cord blood stem cell shipment landmark
Stem cell technology : 01 June, 2009
StemCyte releases its 1,000th cord blood stem cell shipment for transplant, which marks another milestone in the company's rapid growth as one of the world's leading providers of quality, prescription cord blood stem cell product.
 
NeoStem aims to utilise Progenitor Cell Therapy services for stem cell processing
Stem cell technology : 16 April, 2009
NeoStem plans to move its commercial adult stem cells processing and storage operations by exclusively utilising Progenitor Cell Therapy (PCT), a leading international provider of cGMP cell therapy manufacturing and storage.
 
Sigma-Aldrich launches online web portal for stem cell research product portfolio
Stem cell technology : 12 March, 2009
A new online web portal has been launched by Sigma-Aldrich that provides researchers with immediate access to its portfolio of industry-leading products developed specifically for advanced stem cell research.
 
University of Manchester selects protein analysis system from Cell Biosciences
Stem cell technology : 11 March, 2009
Cell Biosciences has made the first UK sales of its flagship protein analysis system to The University of Manchester's Stem Cell and Leukaemia Proteomics Laboratory.
 
Nanoink to host nanofabrication-focused webinar for stem cell research
Stem cell technology : 24 February, 2009
NanoInk is to host a nanofabrication-focused webinar entitled, ′Using Molecular Building Blocks to Create Features in the Nanoworld: Dip Pen Nanolithography’, on Tuesday, April 7, 2009.
 
MaxCyte unveils new transfection system to support stem cell therapy development
Stem cell technology : 18 February, 2009
MaxCyte has introduced the company’s GT Flow Transfection System at the 4th Annual Stem Cell Summit to be held in New York, USA.
 
Neuralstem plans clinical trial tof stem cells o treat amyotrophic lateral sclerosis
Stem cell technology : 19 December, 2008
An Investigational New Drug (IND) application has been files with the US Food and Drug Administration (FDA) by Neuralstem to begin a clinical trial to treat amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).
 
NeoStem opens first ever collection centre for adult stem cells in New York City
Stem cell technology : 05 December, 2008
NeoStem has reached a major milestone with the opening of the first ever collection centre for collection of adult stem cells by the general public for future medical need in New York City and has chosen Bruce Yaffe, MD, Yaffe, Ruden and Associates (founder and partner), a Manhattan based medical practice, to perform collections.
 
Neuralstem collaborateswith Taiwanese hospital to develop spinal cord neural stem cell therapies
Stem cell technology : 03 December, 2008
Neuralstem has entered into a collaboration with the China Medical University and Hospital of Taiwan, to advance development of Neuralstem's human spinal cord neural stem cell therapies.
 
NeoStem targets acquisition of Hong Kong regenerative therapies business
Stem cell technology : 04 November, 2008
NeoStem has agreed to acquire a Hong Kong corporation, whose wholly-owned subsidiary, Beijing HuaMeiTai Bio-technology, has a series of contracts with Shandong New Medicine Research Institute of Integrated Traditional and Western Medicine that establish control over Shandong's business, personnel and finance as though it were a wholly-owned subsidiary.
 
NeoStem receives fresh funds to launch adult stem cell collection network in New York
Stem cell technology : 28 October, 2008
NeoStem, which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need, has closed on a private placement financing in the amount of $250,000.
 
Selexis partners NRC-BRI to offer human cell line for contract research
Stem cell technology : 17 July, 2008
Selexis has partnered with the National Research Counsel of Canada's Biological Research Institute (NRC-BRI) to offer the NRC-BRI HEK293 cell technologies for the contract development of high-performance stable human cell lines enabled by the Selexis Genetic Element and Selexis SURE Cell Line Development Services.
 
NeoStem agrees stem cell collection centre deal
Stem cell technology : 28 May, 2008
NeoStem, a pioneer of pre-disease collection, processing and long-term storage of adult stem cells for future medical needs, has signed a collection centre agreement with the University of Louisville Hospital/ James Graham Brown Cancer Center.
 
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo